According to the UK SmPC, the most common side effects include: Nausea (very common, affecting more than 1 in 10 people): Usually most pronounced during the first few weeks of treatment and often diminishes with continued use Diarrhoea (common, affecting up to 1 in 10 people): Typically mild to moderate in severity Vomiting (common): More frequent at higher doses Constipation (common): May occur alongside other gastrointestinal effects Abdominal pain or discomfort (common): Relatively frequent during treatment initiation Decreased appetite (very common): An expected effect related to the medication's action Dyspepsia/indigestion (common): May contribute to discomfort after eating Beyond gastrointestinal effects, other recognised adverse reactions include injection site reactions (redness, itching, or swelling at the subcutaneous injection site), fatigue , and dizziness
doi: 10.1210/en.2003-0007 111 UssherJRBaggioLLCampbellJEMulvihillEEKimMKabirMGet al
Completing the transformation helps individuals fully appreciate the results of their weight loss journey
As part of this movement, they purport that some of the peptides that are currently banned or not available for the purposes of research should be [available]
"Public Health"
Participants were randomly assigned to receive either a 1.2 mg, 1.8 mg or 2.4 mg dose of ecnoglutide or a placebo